BioLife Solutions (STU:BJX1) Change In Receivables : €14.2 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is BioLife Solutions Change In Receivables?

BioLife Solutions's change in receivables for the quarter that ended in Dec. 2023 was €5.4 Mil. It means BioLife Solutions's Accounts Receivable declined by €5.4 Mil from Sep. 2023 to Dec. 2023 .

BioLife Solutions's change in receivables for the fiscal year that ended in Dec. 2023 was €14.1 Mil. It means BioLife Solutions's Accounts Receivable declined by €14.1 Mil from Dec. 2022 to Dec. 2023 .

BioLife Solutions's Accounts Receivable for the quarter that ended in Dec. 2023 was €17.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BioLife Solutions's Days Sales Outstanding for the three months ended in Dec. 2023 was 52.01.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BioLife Solutions's liquidation value for the three months ended in Dec. 2023 was €11.3 Mil.

BioLife Solutions Change In Receivables Historical Data

The historical data trend for BioLife Solutions's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Change In Receivables Chart

BioLife Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.26

-1.47

-8.97

-10.15

14.08

BioLife Solutions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-1.24	3.37	3.21	2.20	5.42

BioLife Solutions Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €14.2 Mil.

BioLife Solutions (STU:BJX1) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BioLife Solutions's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	17.108	/	30.016	*	91
=	52.01

2. In Ben Graham's calculation of liquidation value, BioLife Solutions's accounts receivable are only considered to be worth 75% of book value:

BioLife Solutions's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	47.404	-	68.822	+	0.75 * 17.108	+	0.5 * 39.849
=	11.3

BioLife Solutions Change In Receivables Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLife Solutions (STU:BJX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BLFS:USA BJX1:Germany

Address

3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021

Website

https://www.biolifesolutions.com

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

BioLife Solutions (STU:BJX1) Headlines

No Headlines